Milestone Pharmaceuticals MIST Stock
Milestone Pharmaceuticals Price Chart
Milestone Pharmaceuticals MIST Financial and Trading Overview
| Milestone Pharmaceuticals stock price | 1.32 USD |
| Previous Close | 1.54 USD |
| Open | 1.52 USD |
| Bid | 1.5 USD x 100 |
| Ask | 1.56 USD x 400 |
| Day's Range | 1.5 - 1.57 USD |
| 52 Week Range | 1.12 - 3.52 USD |
| Volume | 66.69K USD |
| Avg. Volume | 117.51K USD |
| Market Cap | 82.04M USD |
| Beta (5Y Monthly) | 1.724 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.67 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.25 USD |
MIST Valuation Measures
| Enterprise Value | 71.59M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.7906976 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | Infinity |
| Price/Book (mrq) | 3.1884058 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.455 |
Trading Information
Milestone Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.724 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 3.52 USD |
| 52 Week Low | 1.12 USD |
| 50-Day Moving Average | 1.46 USD |
| 200-Day Moving Average | 1.65 USD |
MIST Share Statistics
| Avg. Volume (3 month) | 117.51K USD |
| Avg. Daily Volume (10-Days) | 135.96K USD |
| Shares Outstanding | 53.27M |
| Float | 52.79M |
| Short Ratio | 3.8 |
| % Held by Insiders | 0.69% |
| % Held by Institutions | 56.91% |
| Shares Short | 382.56K |
| Short % of Float | 0.72% |
| Short % of Shares Outstanding | 0.72% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2023 |
| Most Recent Quarter (mrq) | June 30, 2024 |
| Next Fiscal Year End | December 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -33.085% |
| Return on Equity (ttm) | -133.75% |
Income Statement
| Revenue (ttm) | 0 USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -49194000 USD |
| Net Income Avi to Common (ttm) | -48409000 USD |
| Diluted EPS (ttm) | -1.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 83.25M USD |
| Total Cash Per Share (mrq) | 1.26 USD |
| Total Debt (mrq) | 53.25M USD |
| Total Debt/Equity (mrq) | 166.53 USD |
| Current Ratio (mrq) | 19.128 |
| Book Value Per Share (mrq) | 0.483 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -36943000 USD |
| Levered Free Cash Flow (ttm) | -23841876 USD |
Profile of Milestone Pharmaceuticals
| Country | United States |
| State | QC |
| City | Montreal |
| Address | 1111 Dr. Frederik-Philips Boulevard |
| ZIP | H4M 2X6 |
| Phone | 514 336 0444 |
| Website | https://www.milestonepharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 47 |
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans, as well as with the Montreal Heart Institute, the WCN network, and other research centers. The company was incorporated in 2003 and is headquartered in Montréal, Canada.
Q&A For Milestone Pharmaceuticals Stock
What is a current MIST stock price?
Milestone Pharmaceuticals MIST stock price today per share is 1.32 USD.
How to purchase Milestone Pharmaceuticals stock?
You can buy MIST shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Milestone Pharmaceuticals?
The stock symbol or ticker of Milestone Pharmaceuticals is MIST.
Which industry does the Milestone Pharmaceuticals company belong to?
The Milestone Pharmaceuticals industry is Biotechnology.
How many shares does Milestone Pharmaceuticals have in circulation?
The max supply of Milestone Pharmaceuticals shares is 53.35M.
What is Milestone Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Milestone Pharmaceuticals PE Ratio is now.
What was Milestone Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Milestone Pharmaceuticals EPS is -0.67 USD over the trailing 12 months.
Which sector does the Milestone Pharmaceuticals company belong to?
The Milestone Pharmaceuticals sector is Healthcare.
Milestone Pharmaceuticals MIST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17245.05 USD — |
-0.79
|
7.57B USD — | 17128.71 USD — | 17467.35 USD — | — - | 7.57B USD — |
| NASDAQ Global Select Market Com NQGS | 8439.82 USD — |
-0.76
|
— — | 8378.66 USD — | 8543.96 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 925.12 USD — |
+0.17
|
— — | 921.75 USD — | 934.48 USD — | — - | — — |
- {{ link.label }} {{link}}